Zyla Life Sciences Proceeds from Common Stock Issued
Zyla Life Sciences reported Proceeds from Common Stock Issued of $5.23 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-03-26
- Zyla Life Sciences proceeds from issuance of common stock for the quarter ending 2018-12-31 was $12.00K.
- Zyla Life Sciences proceeds from issuance of common stock for the quarter ending 2017-06-30 was $2.80M.
- Zyla Life Sciences proceeds from issuance of common stock for the quarter ending 2017-03-31 was $1.01M.
- Zyla Life Sciences proceeds from issuance of common stock for the quarter ending 2016-12-31 was -$2.00K, a 106.45% decline year-over-year.
- Zyla Life Sciences proceeds from issuance of common stock for fiscal 2018 was $5.23M.
- Zyla Life Sciences proceeds from issuance of common stock for fiscal 2016 was $272.00K, a 99.66% decline from fiscal 2015.
- Zyla Life Sciences proceeds from issuance of common stock for fiscal 2015 was $80.90M, a 20.77% increase from fiscal 2014.
- Zyla Life Sciences proceeds from issuance of common stock for fiscal 2014 was $66.98M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $5.23M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $5.22M 10-Q · filed 2019-11-14 | |||||
| 2017-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.81M 10-Q · filed 2017-08-09 | $3.81M derived: sum of 3 quarters · filed 2017-08-09 | $3.93M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2017-03-31 | $1.01M 10-Q · filed 2017-05-10 | $1.00M derived: sum of 2 quarters · filed 2017-05-10 | $1.12M derived: sum of 3 quarters · filed 2017-05-10 | |||
| 2016-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $117.00K derived: sum of 2 quarters · filed 2017-03-13 | $272.00K 10-K · filed 2017-03-13 | |||
| 2016-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $274.00K 10-Q · filed 2016-11-08 | ||||
| 2016-06-30 | $155.00K 10-Q · filed 2017-08-09 | |||||
| 2015-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $80.81M derived: sum of 2 quarters · filed 2017-03-13 | $80.90M 10-K · filed 2017-03-13 | |||
| 2015-09-30 | $80.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $80.86M 10-Q · filed 2016-11-08 | $80.78M 10-Q · filed 2015-11-06 | |||
| 2015-06-30 | $82.00K 10-Q · filed 2016-08-05 | |||||
| 2014-12-31 | $53.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $53.03M derived: sum of 2 quarters · filed 2017-03-13 | $53.03M derived: sum of 3 quarters · filed 2017-03-13 | $66.98M 10-K · filed 2017-03-13 | $13.95M 10-K · filed 2015-03-16 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $13.95M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $13.95M 10-Q · filed 2015-08-07 | ||||
| 2014-03-31 | $13.95M 10-Q · filed 2015-05-08 |